SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-219248
Filing Date
2020-08-13
Accepted
2020-08-13 17:02:19
Documents
15
Period of Report
2020-08-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d32407d8k.htm   iXBRL 8-K 27123
2 EX-1.1 d32407dex11.htm EX-1.1 185650
3 EX-5.1 d32407dex51.htm EX-5.1 7966
7 GRAPHIC g32407g0813095100130.jpg GRAPHIC 2403
  Complete submission text file 0001193125-20-219248.txt   395718

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA advm-20200812.xsd EX-101.SCH 3067
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE advm-20200812_lab.xml EX-101.LAB 17374
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE advm-20200812_pre.xml EX-101.PRE 10951
8 EXTRACTED XBRL INSTANCE DOCUMENT d32407d8k_htm.xml XML 3214
Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 201100115
SIC: 2836 Biological Products, (No Diagnostic Substances)